LONDON (Alliance News) - Crimson Tide PLC Tuesday said that it has extended its contract with the National Centre for Hereditary Coagulation Disorders, part of St James' Hospital in Dublin, for a further three years.
The provider of mobile data and software solutions, which focuses on simplifying business processes through its mpro smartphone and tablet apps, said that its mpro5 haemophilia smartphone app has been released on the iOS and Android platforms, and the contract extension is worth EU59,000 in contracted revenues, without revenue from further users.
The company claims that the app gives patients greater choice, and is expected to result in an increased number of individuals using the mobile technology.
Crimson Tide shares were 3.3% lower mid-morning Tuesday, trading at 1.31 pence per share.
By Rowena Harris-Doughty; rowenaharrisdoughty@alliancenews.com; @rharrisdoughty
Copyright 2013 Alliance News Limited. All Rights Reserved.
Crimson Tide (TIDE)